News

April 2024

Dr. Luo was awarded a DoD grant!

April 2024

Chenliang was selected to give a flash talk in the PARP meeting at the Cold Spring Harbor Laboratory. Well done!

February 2024

Dr. Luo was awarded a DoD grant!

January 2024

Congratulations to Maowu for his JCI paper!

Maowu's research about ZMYND8 and ferroptosis in BCSCs was just accepted by JCI! Congrats to all authors!

Read More About the Paper

July 2023

Congratulations to Lei for his JCI paper!

Lei's research about SAP30 in breast cancer progression was just accepted by JCI! Congrats to all authors!

Read More About the Paper

April 2023

Dr. Luo was awarded a DoD grant! Postdoc/graduate student positions available!

Postdoc/Graduate student positions are available immediately to study hypoxia-dependent epigenetic and metabolic reprogramming in cancer and brain injuries using various state-of-the-art techniques including next generation sequencing, metabolomics, molecular biology, biochemistry, oncology, and neuroscience. To apply, please send a cover letter, CV, and three reference letters via email to Dr. Weibo Luo (Weibo.Luo@UTSouthwestern.edu).

September 2022

Congratulations to Maowu for his travel award!

Maowu received a travel award from the PDA at UT Southwestern. This award is given to a postdoc who submits the top abstract. Great achievement!

August 2022

Congratulations to Bo and Yan for their Cells paper!

Bo and Yan's GPT2 paper was just published on Cells. Congrats to all authors!

Read More About the Paper

July 2022

Congratulations to Maowu for his Science Advances paper!

Maowu's ZMYND8 paper was just published on Science Advances. Congrats to all authors!
See UTSW News: https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-breast-cancer-development.html

Read More About the Paper

May 2022

Congratulations to Bo and Hui for their Cancer Research paper!

Bo and Hui's BCAT1 paper was just accepted by Cancer Research. Congrats to all authors!
Update: The paper was selected as Featured Article by the Journal!

Read More About the Paper

February 2022

Dr. Luo received a CPRIT grant

Dr. Luo was awarded a CPRIT Individual Investigator Research Award. Postdocs and students are welcome to join the lab!

RAB11B-AS1 paper awarded as the most highly cited paper!

The lncRNA RAB11B-AS1 paper was awarded as the most highly cited paper in Cancer Research during 2020 and 2021. Congrats to Yanling and all coauthors! Amazing achievement!

Postdoc Positions in Weibo Luo Lab

Two postdoctoral positions are available immediately in the laboratory to study hypoxia regulation and drug development in cancer (Cancer Res 2021; Cancer Res 2020; JCI 2018, 128(5): 1937-1955; NAR 2018, 46(13):6576-6591; Cell 2011, 145(5):732-44; PNAS 2012, 109(49): E3367-76).

The Luo Lab is particularly interested in understanding the crosstalk of oxygen homeostasis, epigenetics, and metabolism in breast cancer progression. Cutting-edge techniques including proteomics, next generation sequencing, and metabolomics are used in our studies. Our research is supported by NCI, CPRIT, and private foundations.

We are seeking highly motivated candidates with a Ph.D. or M.D./Ph.D.

Interested candidates must have:

Strong background in biochemistry, molecular biology, and oncology
Strong publication record
Good communication skills
Experience with bioinformatics is a plus. Competitive salary and benefits are offered.

How to Apply
To apply, please send a cover letter, CV, and three reference letters via email to Dr. Luo (Email).

UT Southwestern Medical Center is an Affirmative Action/Equal Opportunity Employer. Women, minorities, veterans, and individuals with disabilities are encouraged to apply.

Graduate Student Positions Available
Graduate students are welcome to join Dr. Luo’s laboratory for their Ph.D. theses. Students who are interested in doing research rotation within the lab, please email Dr. Luo (Email).

Email Dr. Luo

January 2021

Congrats to Yong & Maowu for their paper published by Cancer Research!

Yong & Maowu's ZMYND8 paper have been published by Cancer Research! Nice collaboration! Congrats to All! This paper is highlighted by UTSW News.

Congrats to Lin and Lei for their lncRNA paper in MCR!

A big congratulations to Lin, Lei, and other lab members for their hypoxia-induced lncRNA paper in Mol Cancer Res! Well done!

Read the Paper Here

September 2020

Congrats to Hui for her paper accepted by Oncogene!

Hui's BCAA review article has been published by Oncogene! Well done! Congrats!

Check out Hui's BCAA Article

July 2020

Congrats to Yijie and Yan for their paper accepted by Cancer Research!

Yijie and Yan's CHD4 paper has been accepted by Cancer Research for publication! Great job! Congrats to all!

Check out the Paper Here

July 2020

Congrats to Chenliang for his paper accepted by Journal of Investigative Medicine HIC!

Chenliang's PHD2 paper has been accepted by Journal of Investigative Medicine High Impact Case Reports. A great collaboration with a clinical team at UT Southwestern. Congrats!

Check out the Paper Here

February 2020

Congratulations to Bo's paper on CMLS

Feb. 22, Bo's BCAA paper has been published online in Cellular and Molecular Life Sciences. Congrats to All!

Check out the Paper Here

January 2020

Congratulations to Yanling's paper on Cancer Research

Jan 3rd, 2020, Yanling's RAB11B-AS1 paper is EPubed on Cancer Research. Thank everyone for hard work! Congratulations!

Check out the Paper Here

October 2019

Dr. Luo received a Mary Kay Cancer Research Grant

Dr. Weibo Luo, Assistant Professor and CPRIT Scholar in Cancer Research, received a cancer research grant from the Mary Kay Foundation to study the role of a protein called ZMYND8 in immune response.

Dr. Luo received a CPRIT award

Dr. Weibo Luo, Assistant Professor and CPRIT Scholar in Cancer Research, received a $900,000 Individual Investigator Award from the Cancer Prevention and Research Institute of Texas (CPRIT) to study the role of a protein called ZMYND8 in breast cancer metastasis. Metastasis causes >90% of death due to breast cancer in women and currently cannot be cured. Dr. Luo Lab studies the fundamental mechanisms of breast cancer metastasis and seeks new therapeutic approaches to treat this deadly disease.

Dr. Luo received a Welch award

Dr. Luo successfully renewed his Welch grant to study HIF regulation in breast cancer.

December 2018

Dr. Luo received a R01 from NCI

Dr. Luo received a R01 from NCI to study HIF regulation in breast cancer.

May 2018

Congratulations to Lei for his G9a/GLP paper published on NAR!

Lei's HIF-1α methylation paper has been published on NAR. Congrats and Thank everyone for contribution!

Check out the Paper Here

April 2018

Congratulations to Yan for his paper published in JCI!

Yan's ZMYND8 paper has been published in JCI. Congrats and Thank everyone for contribution!

Check out the Paper Here

October 2017

Congrats to Yan for his PDA travel award!

Yan has won a travel award in the Postdoctoral Research Symposium at UT Southwestern this year. Good Job!

August 2016

Dr. Luo received a Susan G Komen Breast Cancer Research Award

August 2016, Dr. Luo received a Susan G Komen CCR award to study epigenetic regulation of HIF-1 in breast cancer

April 2016

Dr. Luo received a Welch Research Award

April 2016, Dr. Luo received a Welch Research Award for three years to study epigenetic regulation of HIF-1 in GBM.

March 2016

Dr. Luo published an invited editorial in Aging.

February 2016

Dr. Luo Lab published a priority research article in Oncotarget.

Check out the Research Article

May 2015

Dr. Luo received a New Investigator Award

Dr. Luo received a New Investigator Award from the American Cancer Society/Simmons Cancer Center.